Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis.

van't Hoog AH, Cobelens F, Vassall A, van Kampen S, Dorman SE, Alland D, Ellner J.

PLoS One. 2013 Dec 18;8(12):e82786. doi: 10.1371/journal.pone.0082786. eCollection 2013.

PMID:
24367555
[PubMed - in process]
Free PMC Article
2.

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Vassall A, van Kampen S, Sohn H, Michael JS, John KR, den Boon S, Davis JL, Whitelaw A, Nicol MP, Gler MT, Khaliqov A, Zamudio C, Perkins MD, Boehme CC, Cobelens F.

PLoS Med. 2011 Nov;8(11):e1001120. doi: 10.1371/journal.pmed.1001120. Epub 2011 Nov 8.

PMID:
22087078
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD009593. doi: 10.1002/14651858.CD009593.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD009593.

PMID:
23440842
[PubMed - indexed for MEDLINE]
4.

Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.

Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA.

PLoS Med. 2012;9(11):e1001347. doi: 10.1371/journal.pmed.1001347. Epub 2012 Nov 20.

PMID:
23185139
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.

Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, Ntinginya EN, O'Grady J, Huggett J, Dheda K, Boehme C, Perkins M, Saathoff E, Hoelscher M.

PLoS One. 2011;6(6):e20458. doi: 10.1371/journal.pone.0020458. Epub 2011 Jun 29.

PMID:
21738575
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.

Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W.

PLoS Med. 2011 Jul;8(7):e1001061. doi: 10.1371/journal.pmed.1001061. Epub 2011 Jul 26.

PMID:
21814495
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.

Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K.

Eur Respir J. 2013 Sep;42(3):708-20. doi: 10.1183/09031936.00147912. Epub 2012 Dec 20.

PMID:
23258774
[PubMed - indexed for MEDLINE]
Free Article
8.

Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States.

Choi HW, Miele K, Dowdy D, Shah M.

Int J Tuberc Lung Dis. 2013 Oct;17(10):1328-35. doi: 10.5588/ijtld.13.0095.

PMID:
24025386
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?

Theron G, Pooran A, Peter J, van Zyl-Smit R, Kumar Mishra H, Meldau R, Calligaro G, Allwood B, Sharma SK, Dawson R, Dheda K.

Eur Respir J. 2012 Jul;40(1):161-8. doi: 10.1183/09031936.00145511. Epub 2011 Nov 10.

PMID:
22075479
[PubMed - indexed for MEDLINE]
Free Article
10.

Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa.

Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S.

S Afr Med J. 2013 Jan 14;103(2):101-6. doi: 10.7196/samj.6182.

PMID:
23374320
[PubMed - indexed for MEDLINE]
11.

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.

Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K.

Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40. doi: 10.1164/rccm.201101-0056OC. Epub 2011 Apr 14.

PMID:
21493734
[PubMed - indexed for MEDLINE]
12.

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.

Andrews JR, Lawn SD, Rusu C, Wood R, Noubary F, Bender MA, Horsburgh CR, Losina E, Freedberg KA, Walensky RP.

AIDS. 2012 May 15;26(8):987-95. doi: 10.1097/QAD.0b013e3283522d47.

PMID:
22333751
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R.

PLoS Med. 2011 Jul;8(7):e1001067. doi: 10.1371/journal.pmed.1001067. Epub 2011 Jul 26.

PMID:
21818180
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.

Balcha TT, Sturegård E, Winqvist N, Skogmar S, Reepalu A, Jemal ZH, Tibesso G, Schön T, Björkman P.

PLoS One. 2014 Jan 22;9(1):e85478. doi: 10.1371/journal.pone.0085478. eCollection 2014.

PMID:
24465572
[PubMed - in process]
Free PMC Article
15.

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD.

Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.

PMID:
21507477
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey.

Dorman SE, Chihota VN, Lewis JJ, Shah M, Clark D, Grant AD, Churchyard GJ, Fielding KL.

PLoS One. 2012;7(8):e43307. doi: 10.1371/journal.pone.0043307. Epub 2012 Aug 15.

PMID:
22905254
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.

Yoon C, Cattamanchi A, Davis JL, Worodria W, den Boon S, Kalema N, Katagira W, Kaswabuli S, Miller C, Andama A, Albert H, Nabeta P, Gray C, Ayakaka I, Huang L.

PLoS One. 2012;7(11):e48599. doi: 10.1371/journal.pone.0048599. Epub 2012 Nov 6.

PMID:
23139799
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa.

Meyer-Rath G, Schnippel K, Long L, MacLeod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S.

PLoS One. 2012;7(5):e36966. doi: 10.1371/journal.pone.0036966. Epub 2012 May 31.

PMID:
22693561
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Evaluation of Cepheid's Xpert MTB/RIF Test on Pleural Fluid in the Diagnosis of Pleural Tuberculosis in a High Prevalence HIV/TB Setting.

Lusiba JK, Nakiyingi L, Kirenga BJ, Kiragga A, Lukande R, Nsereko M, Ssengooba W, Katamba A, Worodria W, Joloba ML, Mayanja-Kizza H.

PLoS One. 2014 Jul 22;9(7):e102702. doi: 10.1371/journal.pone.0102702. eCollection 2014.

PMID:
25051491
[PubMed - as supplied by publisher]
20.

Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study.

Sekadde MP, Wobudeya E, Joloba ML, Ssengooba W, Kisembo H, Bakeera-Kitaka S, Musoke P.

BMC Infect Dis. 2013 Mar 12;13:133. doi: 10.1186/1471-2334-13-133.

PMID:
23497044
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk